Immunotherapy

CAR T-Cell Therapies – Now Targeting Solid Tumors

Most in oncology drug development are aware of…
Read Article

Managing the Side Effects in a CAR T-cell Therapy Study

CAR T-cell therapy, together with checkpoint inhibition, has…
Read Article

Common Causes of Delays in Immuno-Oncology Studies

It’s common for “standard” oncology studies to encounter…
Read Article

Challenges with Checkpoint Inhibitors in the Clinic

Checkpoint inhibitors, including those targeting PD-1 and PD-L1,…
Read Article

Guidelines for the Evaluation of Immune Therapy Activity

In a previous article, we discussed therapies that…
Read Article